SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-019967
Filing Date
2021-04-02
Accepted
2021-04-02 16:43:52
Documents
2
Period of Report
2021-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea138936-8k_180lifesciences.htm 8-K 25309
2 FIRST AMENDMENT TO CONSULTANCY AGREEMENT DATED MARCH 23, 2021, BY AND BETWEEN 18 ea138936ex10-2_180life.htm EX-10.2 83973
  Complete submission text file 0001213900-21-019967.txt   110578
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 21802522
SIC: 2834 Pharmaceutical Preparations